FDA Authorizes Pharmacists to Prescribe Paxlovid
WEDNESDAY, July 20, 2022 -- Today, the U.S. Food and Drug Administration revised the Emergency Use Authorization (EUA) for Paxlovid (nirmatrelvir and ritonavir), to authorize state-licensed pharmacists to prescribe Paxlovid to eligible patients,...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials
More News: Clinical Trials | Emergency Medicine | Food and Drug Administration (FDA) | Norvir | Pharmaceuticals